Activities, Bill Numbers and Titles
|
|
Client: Johnson & Johnson Services, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $29,223.41
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1272
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
786
|
An Act to bring down the cost of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1278
|
An Act relative to prescription drug price transparency
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|